University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut ...

Researchers developed and validated a nomogram to predict 1-, 2-, and 3-year overall survival (OS) in patients with ovarian cancer and liver metastases (OCLM), outperforming an external model in ...

Some risk factors for epithelial ovarian cancer are modifiable, according to a study published online Jan. 6 in the I ...

Every cell in the body normally has its fixed place as part of a tissue structure. Except for a few cell types, such as blood ...

However, researchers at the Penn Ovarian Cancer Research Center at the University of Pennsylvania are studying a surprising ...

Traditionally, chemotherapy was given after surgery (primary cytoreductive surgery (PCRS) and adjuvant chemotherapy). However, chemotherapy can be used before surgery (neoadjuvant chemotherapy (NACT) ...

Further, researchers discovered some characteristics of red blood cells and liver enzymes in the blood associated with ovarian cancer risk. “It was particularly interesting that some blood ...

Results from the PEACOCC trial warrant further investigation into treatment with pembrolizumab in patients with previously ...

At the Research Awards 2024, we had the pleasure of hearing from Professor Anna DeFazio AM, University of Sydney, who heads ...